The graphic in the News story ‘Ebola drug trials set to begin amid crisis’ (Nature 513, 13–14; 2014) said that the NIAID/GSK vaccine had been shown to be safe in ‘preclinical human trials’. In fact, two components of the vaccine have been shown to be safe in other phase I trials, and the vaccine itself is about to enter phase I clinical trials.
Additional information
The online version of the original article can be found at 10.1038/513013a
Related links
Related links
Related links in Nature Research
Related external links
Rights and permissions
About this article
Cite this article
Correction. Nature 513, 156 (2014). https://doi.org/10.1038/513156b
Published:
Issue Date:
DOI: https://doi.org/10.1038/513156b
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
